Oxford Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Oxford Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-44,767	Closed	-$202K	–	1509
2019 Q4	$202K	Buy	44,767 +21,435	+92%	+$67.8K	0.01%	1553
2019 Q3	$97K	Sell	23,332 -77,364	-77%	-$279K	﹤0.01%	1633
2019 Q2	$382K	Sell	100,696 -20,462	-17%	-$83.9K	0.01%	1374
2019 Q1	$508K	Sell	121,158 -17,573	-13%	-$61.4K	0.01%	1211
2018 Q4	$345K	Buy	138,731 +113,671	+454%	+$666K	0.01%	1342
2018 Q3	$179K	Buy	+25,060	New	+$110K	﹤0.01%	1612
2017 Q2	–	Sell	-160,953	Closed	-$1.11M	–	1756
2017 Q1	$1.11M	Sell	160,953 -25,028	-13%	-$196K	0.03%	763
2016 Q4	$1.74M	Sell	185,981 -1,488	-0.8%	-$13.4K	0.06%	364
2016 Q3	$1.83M	Buy	187,469 +23,152	+14%	+$312K	0.06%	417
2016 Q2	$2.32M	Sell	164,317 -1,771	-1%	-$27.6K	0.08%	339
2016 Q1	$2.32M	Buy	+166,088	New	+$2.44M	0.07%	336

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Oxford Asset Management's AGTC Position: Q1 2020 in Review

Oxford Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2020, closing a stake of 44,767 shares — an estimated $202K sold.

Oxford Asset Management first reported a position in AGTC in Q1 2016 and held it in 11 quarters. The position peaked at $2.32M in Q2 2016. 59 funds tracked by Wall St. Rank hold AGTC as of Q1 2020.

Oxford Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 44,767 Applied Genetic Technologies Corporation shares in Q1 2020, an estimated $202K.
Oxford Asset Management first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and held it in 11 quarters.
Oxford Asset Management's Applied Genetic Technologies Corporation position peaked at $2.32M in Q2 2016.
59 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.